pharmaphorum December 27, 2023
Phil Taylor

Apple has resumed the sale of some of its smartwatches in the US, after filing an emergency appeal against a decision by the Biden administration not to veto a ban on imports.

Sales of the Series 9 and Ultra 2 Apple Watches had been paused in the US over a complaint that the devices violate patents held by Masimo on the use of wearables to measure blood oxygen levels.

Earlier this week, US Trade Representative (USTR) Katherine Tai declined to veto an earlier International Trade Commission (ITC) ruling that concluded some Apple Watches infringe intellectual property on the use of light-based pulse oximetry, namely US patent numbers 10,912,502 or 10,945,648, attributed to Masimo and Cercacor Labs.

That limited exclusion order...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article